Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Reference number: TA275
Published: 27 February 2013
Last updated: 02 July 2021

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Bristol-Meyers Squibb and Pfizer response to clarification points

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Bristol-Meyers Squibb and Pfizer response to clarification points

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: Bristol-Meyers Squibb and Pfizer response to clarification points
23 January 2013
(975.64 Kb 44 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 21 January 2013